ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ)

$2.63 -0.07 (-2.5926%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 86

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) News Sources

Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026

05-05-2026

yahoo.com

Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference

07-05-2026

yahoo.com

Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights

12-05-2026

yahoo.com

Acumen Pharmaceuticals Q1 Earnings Call Highlights

12-05-2026

marketbeat.com

Acumen Pharmaceuticals Inc (ABOS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...

12-05-2026

yahoo.com

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease

16-06-2026

yahoo.com

Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease

16-06-2026

yahoo.com

JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform

17-06-2026

yahoo.com

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

07-07-2026

yahoo.com

Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer's Disease Clinical Programs

09-07-2026

yahoo.com

ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) Sentiment Trend

0 25 50 75 100 77 83 85 93 93 86 78 89 88 92 05-05-2026 07-05-2026 12-05-2026 16-06-2026 17-06-2026 07-07-2026 09-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) FAQs

toggle

What is the current price of ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ)?

The current price of ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) is $2.63.


toggle

ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) absolute price change since previous trading day?

The absolute price change of ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) since the previous trading day is $-0.07.


toggle

ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) percentage price change since previous trading day?

The percentage price change of ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) since the previous trading day is -2.5926%.


toggle

What is the most recent average sentiment score for ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ)?

The most recent average sentiment score for ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) is 86 out of 100.


toggle

What is the most recent average sentiment for ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ)?

The most recent sentiment for ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ) is .


SEC-8K** Filing Available For ACUMEN PHARMACEUTICALS INC (ABOS:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.